
Modern zzso zzso B virus and zzso C virus zzso therapies have been successful at keeping viruses suppressed for prolonged periods of time, but therapy failures attributable to the emergence of drug resistant zzso continue to be a zzso reminder that no therapy can fully eradicate these viruses from their host zzso To better understand the emergence of drug resistance, we combined zzso and statistical models of viral evolution in a zzso zzso approach that reconstructs zzso pathways of drug zzso 

The first phase of the zzso involved the modeling of the evolution of the virus within the human host zzso The inclusion of zzso zzso sequence data was a key aspect of the model due to the progressive fashion in which multiple zzso become linked in the same zzso creating drug resistant zzso The second phase involved the development of a zzso model to calculate the transition probabilities between the different zzso The proposed method was applied to data from an zzso zzso clinical trial zzso The obtained model revealed the direction of evolution over time with greater detail than previous zzso Our results show that the zzso pathways facilitate the identification of fast versus slow evolutionary pathways to drug zzso 

zzso code for the zzso is publicly available at zzso 

